Skip to content

Brandon M Weiss

3 papers in the library · 20 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Psychological support can be distinguished from psychotherapy: Clarifications for future empirical work.

General Hospital Psychiatry 2026 Jonathan R Schettino, Katherine Cheung, Sandeep M. Nayak et al.

Classic psychedelic studies involve interpersonal interactions with participants before, during, and after the acute effects of psychedelics. In the field of psychedelic research, there is currently a debate about whether this interpersonal interaction is most accurately considered "psychological support," "psychotherapy," or something else. Proponents of the psychological support label...

Exploring serotonergic psychedelics as a treatment for personality disorders.

Neuropharmacology July 1, 2025 Brennan M. Carrithers, Daniel E. Roberts, Brandon M Weiss et al. 4 citations

Both psychotherapeutic interventions and pharmacological agents have demonstrated limited efficacy in the treatment of personality disorders (PDs). Emerging evidence suggests that psychedelic therapy, already showing promise in treating various psychiatric conditions commonly comorbid with PDs, may exert therapeutic effects by promoting adaptive changes in personality. Thus, psychedelic therapy...

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial.

Frontiers in Psychiatry 2023 Ellen James, David Erritzøe, Tiffanie Benway et al. 16 citations

Due to their potential impact on mood and wellbeing there has been increasing interest in the potential of serotonergic psychedelics such as N,N-dimethyltryptamine (DMT) in the treatment of major depressive disorder (MDD). The aim of Part A of this study was to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) profile of escalating doses of SPL026 (DMT fumarate)...